Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose

Hormone and Metabolic Research

Volumn 31, Issue 2-3, 1999, Pages 90-96

  Russell, J W ^a,b   Feldman, E L ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

Cell death; Hyperglycemia; IGF I receptor; Sympathetic ganglia

Indexed keywords

GLUCOSE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CERVICAL GANGLION; DIABETIC NEUROPATHY; HYPERGLYCEMIA; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ANIMALIA;

EID: 0032958415     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978704     Document Type: Article

References (53)

1. 1. Greene DA, Feldman EL, Stevens MJ, Sima AAF, Albers JW, Pfeifer MA. Diabetic Neuropathy. In: Porte Jr D, Sherwin R, Rifkin H (eds). Diabetes Mellitus.East Norwalk, CT Appleton & Lange 1995
2. 2. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA. Complications: Neuropathy, pathogenetic considerations. Diabetes Care 1992; 15: 1902-25
3. 3. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
4. 4. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561-8
5. 5. Crofford OB. Diabetes control and complications. Ann Rev Med 1995; 46: 267-79
6. 6. Russell JW, Feldmann EL. Insulin-like growth factor-I (IGF-I) protects sensory neurons from glucotoxicity. Ann Neurol (Abstract) 1996; 40: 510
7. 7. Russell JW, Sullivan KA, Herrmann DN, Feldman EL. Hyperglycemia induces programmed cell death in sensory neurons in vivo and in vitro. The Endocrine Society (Abstract) 1998; 218: P1-P475
8. 8. Geisthovel F, Moretti-Rojas I, Rojas FJ, Asch RH. Insulin-like growth factors and thecal-granulosa-cell function. Hum Reprod 1990; 5 (7): 785-99
9. 9. Russell JW, van Golen C, Parekh A, Singleton JR, Feldman EL. Insulin-like growth factor I prevents programmed cell death in neurons. Diabetologia 1997; 40 (Suppl.): A549
10. 10. von Golen CM, Feldman EL. The effect of insulin-like growth factor I on caspase activation in human neuroblastoma. Mol Biol Cell (Abstract) 1997; 8 (Suppl.): 148A
11. 11. Zigler D. Electrophysiological assessment: relationship to glycaemic control. In: Hotta N, Greene DA, Ward JD, Sima AAF, Boulton AJM (eds). Diabetic Neuropathy. Amsterdam Elsevier 1995: 59-69
12. 12. Matthews CC, Odeh H, Feldman EL. Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience 1997; 79: 525-34
13. 13. Singleton JR, Dixit VM, Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 1996; 271: 31791-4
14. 14. Zhuang HX, Synder CK, Pu SF, Ishii DN. Insulin-like growth factors reverse or arrest diabetic neuropathy: Effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996; 140: 198-205
15. 15. Windebank AJ, Smith AG, Russell JW. The effect of ACTH analogs on cisplatinum neurotoxicity in vitro. Neurology 1994; 44: 488-94
16. 16. Ruit KG, Osborne PA, Schmidt RE, Johnson Jr EM, Snider WD. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci 1990; 10: 2412-9
17. 17. Deckwerth TL, Johnson Jr EM. Neuntes can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Devel Biol 1994; 165: 63-72
18. 18. Windebank AJ, Blexrud MD. Characteristics of neurite outgrowth from rat spinal ganglia: Effects of serum and segmental level. J Neuropathol Exp Neurol 1986; 45: 683-91
19. 19. Russell JW, Windebank AJ, Podratz JL. Role of nerve growth factor in suramin neurotoxicity studied in vitro. Ann Neurol 1994; 36: 221-8
20. 20. Schmilz GG, Walter T, Seibl R, Kessler C. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 1991; 192: 222-31
21. 21. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1993; 119: 493-501
22. 22. Russell JW, Windebank AJ, McNiven MA, Brat DJ, Brimijoin WS. Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res 1995; 676: 258-67
23. 23. Feldman EL, Sullivan KA, Kim B, Russell JW. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol Dis 1997; 4: 201-14
24. 24. Wright LL, Cunningham TJ, Smolen AJ. Developmental neuron death in the rat superior cervical sympathetic ganglion: cell counts and ultrastructure. J Neurocytol 1983; 12: 727-38
25. 25. Raff MC. Social controls on cell survival and cell death. Nature 1992; 356: 397-400
26. 26. Freeman RS, Estus S, Johnson Jr EM. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 1994; 12: 343-55
27. 27. Pirart J. Diabetes mellitus and its degenerative complications; a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-88
28. 28. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995; 16: 3-34
29. 29. Muller Y, Tangre K, Clos J. Autocrine regulation of apoptosis and bcl-2 expression by nerve growth factor in early differentiating cerebellar granule neurons involves low affinity neurotrophin receptor. Neurochem Int 1997; 31: 177-91
30. 30. Cheng B, Mattson MP. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci 1992; 12: 1558-66
31. 31. Gandhi D, Matthews CC, Feldman EL. IGF-I rescues neurons from hyperglycemic, hyperosmotic injury. In: Hotta N, Greene DA, Ward JD, Sima F, Boulton AJM (eds). Diabetic neuropathy: new concepts and insights. Elsevier Science B.V. 1995: 183-9
32. 32. Matthews CC, Feldman EL. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J Cell Physiol 1996; 166: 323-31
33. 33. Thomas TP, Feldman EL, Nakamura J, Kato K, Lien M, Stevens MJ, Greene DA. Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal epithelial cells in culture. Proc Natl Acad Sci USA 1993; 90: 9712-6
34. 34. Singleton JR, Randolph AE, Feldman EL. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res 1996; 56: 4522-9
35. 35. Baserga R. The insulin-like growth factor I receptor: A key to tumor growth? Cancer Res 1995; 55: 249-52
36. 36. Baserga R. Oncogenes and the strategy of growth factors. Cell 1994; 79: 927-30
37. 37. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J. Loss of tumorigenicity of rat glioblastoma directed by episomebased antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 1992; 89: 4874-8
38. 38. Prager D, Li H-L, Asa S, Melmed S. Dominant negative inhibition of tumorigenesis in vitro by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 1994; 91: 2181-5
39. 39. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6
40. 40. Davies AM. The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci 1995; 18: 355-8
41. 41. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6
42. 42. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zheng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-9
43. 43. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin T-T, Nicholson DW. CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in fas-mediated apoptosis. J Biol Chem 1996; 271: 1841-4
44. 44. Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995; 377: 446-8
45. 45. Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He W-W, Dixit VM. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas-and tumor necrosis factor-induced apoptosis. J Biol Chem 1996; 271: 1621-5
46. 46. Martin DP, Ito A, Horigome K, Lampe PA, Johnson Jr EM. Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J Neurobiol 1992; 23: 1205-16
47. 47. Edwards SN, Backmaster AE, Tolkovsky AM. The death programme in cultured sympathetic neurons can be suppressed at the post translational level by nerve growth factor, cyclic AMP and depolarization. J Neurochem 1991; 57: 2140-3
48. 48. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992; 258: 302-4
49. 49. Russell JW, Parekh A, Singleton JR, Feldman EL. Insulin-like growth factor-I (IGF-I) modulates programmed cell death pathways in hyperglycemic neurons. Ann Neurol 1996; 40: 954
50. 50. Moses AC, Young SCJ, Morrow LA, O'Brien M, Clemmons DR. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 1996; 45: 91-100
51. 51. Leventhal PS, Shelden EA, Kim B, Feldman EL. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance. J Biol Chem 1997; 272: 5214-8
52. 52. Leventhal PS, Feldman EL. Insulin-like growth factors as regulators of cell motility: signaling mechanisms. Trends Endocrinol Metab 1997; 8: 1-6
53. 53. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-25